588 Peginterferon α-2a (40 kDa) plus ribavirin is as effective in patients relapsing after conventional interferon based therapy as in naive patients: Results from the bernar-1 trial
- 30 April 2005
- journal article
- abstracts
- Published by Elsevier in Journal of Hepatology
- Vol. 42, 214
- https://doi.org/10.1016/s0168-8278(05)81999-3
Abstract
No abstract availableKeywords
This publication has 0 references indexed in Scilit: